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Background: Using the piggyBac-mediated GAL4/UAS transgenic system established in the silkworm, Bombyx mori,
we have previously reported that overexpression of the Ras1CA oncogene specifically in the posterior silk gland
(PSG) improved cell growth, fibroin synthesis, and thus silk yield. However, the detailed molecular mechanism
remains to be fully elucidated. To achieve this goal, Illumina sequencing was used in the present study to compare
the transcriptomes of the Ras1CA-overexpressed and wildtype PSGs.
Results: The transcriptomic sequencing results in 56 million reads following filtering steps. Most of the reads
(~70%) are successfully mapped to the Bombyx genome. The mapped reads are situated within at least 9,133
predicted genes, covering 62.46% genes of the Bombyx genome. GO annotation shows that 2512 of the 2,636
differentially expressed genes (DEGs) are mostly distributed in metabolic process, cell and cell part, and binding,
and KEGG annotation shows that 1,941 DEGs are mapped into 277 pathways. Importantly, Ras1CA overexpression in
the PSG upregulated many DEGs distributed in “pathways in cancer”, “insulin signaling pathway”, and “MAPK
signaling pathway” as well as “purine metabolism” and “pyrimidine metabolism”. Transcriptional regulation of these
DEGs was verified by quantitative real-time PCR. Moreover, injection of small-molecule chemical inhibitors of the
Ras1 downstream effectors into the Ras1CA-overexpressed silkworms revealed that both Raf-MAPK and PI3K-TORC1
pathways are required for the Ras1-induced DEG expression.
Conclusion: The transcriptomic analysis illustrates that, apart from phosphorylational regulation, Ras1 activates its
downstream Raf-MAPK and PI3K-TORC1 pathways at the transcriptional level. Meanwhile, Ras1 increases DNA content
and induces endoreplication, at least in part, by upregulating genes in “nucleotide metabolism” and “cell cycle”.
This study provides further insights into the molecular mechanism of how Ras1CA overexpression in the PSG
improves silk yield.Background
As a traditional agricultural industry, sericulture is eco-
nomically important to China and several other coun-
tries. The domesticated silkworm, Bombyx mori, is the
most important insect species for sericulture. In the
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reproduction in any medium, provided the orthe hybrid breeding technique to Bombyx. However, it
has reached a plateau during the last decades, mostly
due to the inherent threshold of this technique. To
break through the bottleneck of silk production, new
breeding techniques, such as the molecular breeding
technique, should be developed. It has been hypothe-
sized that fibroin production in the Bombyx posterior
silk gland (PSG) is directly proportional to silk yield and
determined by its gland size and protein synthesis [1],
making it possible to improve silk yield by genetic ma-
nipulation of the PSG [2]. On the other hand, Bombyx
has been used as a model lepidopteran insect for a long
time [3,4]. In terms of protein synthesis, its PSG is one
of the most efficient organs in animals. Therefore,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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synthesis in the Bombyx PSG is of great value for both
applied and basic research.
Using the piggyBac-mediated GAL4/UAS transgenic
system established in Bombyx [5-7], we specifically over-
expressed a constitutively active form of Ras1 (Ras1CA)
in the PSG. In the transgenic silkworm, Fil-GAL4 >UAS-
Ras1CA (Fil > Ras1CA), Ras1CA overexpression increases
gland size and protein synthesis in the PSG, leading to
silk yield improvement by 60% [2]. This study not only
provides an application prospect to silk yield improve-
ment in sericulture, but also supports the previous hy-
pothesis that fibroin production is determined by gland
size and protein synthesis in the PSG [1]. It is certain
that Ras1 and its downstream Raf-MAPK and PI3K-
TORC1 pathways play critical roles in regulating fibroin
production [2], while the detailed molecular mechanism
remains to be fully elucidated. The completed Bombyx
genome sequence [8,9] makes it possible to use functional
genomics, such as proteomics and transcriptomics, to
achieve the above goal. Using 2D-DIGE-MS/MS analysis,
we previously compared the proteomic profiles of the
Ras1CA-overexpressed and wild type (WT) PSGs. Further
studies revealed that, via the downstream Raf-MAPK and
PI3K-TORC1 pathways, Ras1CA upregulates bcpi, which
inhibits cathepsin activity thus preventing PSG destruc-
tion during metamorphosis [10]. Transcriptomics could
be an alternative approach for analyzing how Ras1CA over-
expression in the PSG improves fibroin production.
In terms of transcriptomic tools, a whole-genome
microarray containing 22,987 oligonucleotides of 70-mers
that cover the presently known and predicted genes in the
Bombyx genome was designed on the basis of the whole-
genome sequences [11]. This microarray has been used to
survey the silkworm gene expression patterns in multiple
tissues, at different developmental stages, and under
various conditions or treatments [11-15]. RNA-Seq
(also known as Next Generation Sequencing), including
Roche/454 pyrosequencing, Illumina-Solexa sequencing,
and Applied Biosystems SOLiD sequencing, has led to a
revolution in genomics and provided cheaper and faster
delivery of sequencing information [16]. The Illumina-
Solexa sequencing strategy was adopted for the sequen-
cing of 40 Bombyx genomes from 29 phenotypically and
geographically diverse domesticated silkworm lines and
11 wild silkworms from various mulberry fields inTable 1 Raw data preprocessed results
Sample Raw data
Read Base Read
WT 33218225 3321822500 26436677
Fil > Ras1CA 36443802 3644380200 29987342
All 69662027 6966202700 56424019China. This comprehensive study constructs a genome-
wide genetic variation map which shed light on the history
of silkworm domestication [9]. RNA-Seq also led to the
identification of new exons, novel genes, alternative spli-
cing genes, and trans-splicing events in Bombyx [17,18].
In this study, Illumina-Solexa sequencing revealed
2,636 differentially expressed genes (DEGs) in the
Ras1CA-overexpressed and WT PSGs. Confirmed by
quantitative real-time PCR (qPCR), the transcriptomic
analysis shows that Ras1 increases gland size, protein
synthesis, and DNA content in the PSG at the transcrip-
tional level.Results
Identification of DEGs using RNA-seq
For better understanding the molecular mechanism how
Ras1CA overexpression increases fibroin production in the
Bombyx PSG, we compared the transcriptomes of the
Ras1CA-overexpressed and WT PSGs at the early wander-
ing stage. The RNA-seq raw data were deposited to NCBI
SRA with the accession number SRP026709 (http://www.
ncbi.nlm.nih.gov/sra/?term=SRP026709). The accession
numbers for the two WT PSG RNA-seq libraries are
SRX320122 and SRX320124, and those for the two Ras1CA-
overexpressed PSG RNA-seq libraries are SRX320125 and
SRX320126. The RNA-seq raw data of SRX320122 and
SRX320124 were combined for raw data processing, so were
SRX320125 and SRX320126. Using the pair-end Illumina-
Solexa sequencing strategy, we obtained 69,662,027 raw
reads, containing about 6.9 gigabases with an average read
length of 101 nucleotides. The raw data was preprocessed,
and 13,238,008 (19%) low quality reads were removed.
The remaining 56,424,019 reads, with an average length of
90.71 nucleotides (Table 1), were used to map the Bombyx
genome (release_2.0) [19] using TopHat [20].
In total, 39,967,028 reads were mapped to silkworm
genome database (silkgenome.fa) and silkworm gene data-
base (silkworm_glean.gff), with approximately 2.2 and 1.8
million reads from the Ras1CA-overexpressed and WT
PSGs, respectively. The completed Bombyx genome con-
tains 14,623 unigenes [8,9]. Using the Fragments Per kb
Per Million Reads (FPKM) method [21], we have found
that 9,133 unigenes are expressed, with 6,962 and 6,429
unigenes in the Ras1CA-overexpressed and WT PSGs, res-
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in this study (Table 2).
Importantly, RNA-Seq revealed 2,636 DEGs, with 1708
upregulated and 938 downregulated genes in the Ras1CA-
overexpressed PSG compared to the WT PSG (Figure 1).
Next, the DEGs were subjected to functional annotation
and qPCR verification.Functional annotation of DEGs
Gene ontology (GO) assignments were used to classify the
functions of DEGs revealed by transcriptomic analysis. The
DEGs were termed by GO ontology in three categories,
namely biological process, cellular component, and molecu-
lar function. In total, 2512 DEGs (95.3% of 2636) were anno-
tated in 60 GO functional groups (Figure 2). In the category
of biological process, over 43% of DEGs were distributed in
“metabolic process”, nearly 40% DEGs were classified into
“cellular process”, while very few DEGs were found in
“growth”, “carbon utilization”, “viral reproduction”, “rhyth-
mic process”, and “locomotion” (Figure 2A). In the cate-
gory of cellular component, over 35% of DEGs were
distributed in “cell” and “cell part”, however, very small
numbers of DEGs were found in “virion part”, “synapse”,
and “extracellular matrix part” (Figure 2B). In the category
of molecular function, the terms “binding” and “catalytic
activity” enriched 32% and 30% of DEGs, respectively.
By contrast, few DEGs were distributed in “channel
regulator activity”, “receptor regulator activity”, and
“metallochaperone activity” (Figure 2C).
To identify the biological pathways that are active in
the Ras1CA-overexpressed PSG, we mapped the DEGs to
the reference canonical pathways in Kyoto Encyclopedia
of Genes and Genomes (KEGG) [22]. Among the 2636
DEGs, 1,941 sequences predicted to encode enzymes
with enzyme commission (EC) numbers were mapped
into 277 KEGG pathways. The top 25 KEGG pathways
are shown in Table 3. The top 5 KEGG pathways with
most representations by the DEGs were “purine metabo-
lism”, “spliceosome”, “pathways in cancer”, “RNA trans-
port”, and “HTLV-1 infection”, implying that these
diverse metabolic processes are active in the Ras1CA-
overexpressed PSG. “Purine metabolism” is essential,
providing components of the nucleotides, DNA and
RNA, and the energy currency of the cell, ATP [23]. In
parallel, “Pyrimidine metabolism” also ranks on the top
6 KEGG pathway (Table 3). In the Ras1CA-overexpressedTable 2 Evaluation of valid reads mapped to reference genom
QC data Mapp_reads Ma
WT 26436677 17583378 66.
Fil > Ras1CA 29987342 22383650 73.
All 56424019 39967028 70.PSG, the DNA content is nearly doubled and endoreplica-
tion is enhanced in comparison with the WT PSG, indi-
cating that more active nucleotide metabolism is required
[2]. “Spliceosome” is complex molecular machinery in-
volved in removal of introns from mRNA precursors [24].
A lot of DEGs in this pathway suggest occurrence of high
frequency of mRNA splicing for translation in the Ras1CA-
overexpressed PSG. Interestingly, a large number of DEGs
are found distributed in “pathways in cancer”. As an import-
ant oncogene, Ras plays important roles in both normal de-
velopment and aberrant biological processes, such as
tumorigenesis and developmental disorders [25]. It is likely
that, apart from the phosphorylational regulation, Ras could
also activate “pathways in cancer” at the transcriptional level.
“RNA transport” from the nucleus to the cytoplasm is fun-
damental for gene expression regulation. Most eukaryotic
RNAs are produced in the nucleus by RNA polymerase I, II,
or III. The RNA molecules undergo a variety of posttran-
scriptional processing events, and a majority of them are lo-
calized to their functional sites in the cell [26]. In
accordance with this result, ribosome biogenesis for mRNA
translation was stimulated in the Ras1CA-overexpressed
PSG [2]. Unexpectedly, some DEGs were annotated into
“HTLV-1 infection pathway”, but the silkworm cannot be af-
fected by this human virus. Our preliminary data shows that
virus-resistance is enhanced when Ras1CA is globally overex-
pressed in the transgenic silkworm, Actin3-GAL4 >UAS-
Ras1CA, suggesting that the DEGs in “HTLV-1 infection
pathway” might play a role in antivirus in Bombyx.
In short, these annotations provide a valuable insight
into the specific processes, functions, and pathways and
facilitate the identification of DEGs resulted from the
Ras1CA-overexpressed PSG. Next, the DEGs in several
important and top KEGG pathways were chosen for
qPCR verification (Table 3).qPCR verification of DEGs in “pathways in cancer”, “insulin
signaling pathway”, and “MAPK signaling pathway”
In our previous study, we have determined that Ras1CA
overexpression in the PSG increases Ras activity, resulting
in phosphorylation of the Ras downstream effector proteins,
Raf and PI3K110, which in turn activate the Raf-MAPK and
PI3K-TORC1 pathways, respectively [2]. Surprisingly,
among all the 277 KEGG pathways, a large number of
DEGs are distributed in “pathways in cancer”, “insulin
signaling”, and “MAPK signaling pathway” (Additional filee of each sample
pp% Unigenes Junc_reads Junc%
54% 6429 5694420 21.62%
35% 6962 7878212 25.33%


























Figure 1 Gene expression in Ras1CA-overexpressed and WT
PSGs. All reads were aligned to predicted genes and are shown as
log10 values derived from cDNAs of the Ras1CA-overexpressed and
WT PSGs (F-test, P, <2.2 × 10−16). The Ras1-upregulated genes and
downregulated genes are marked with red and green
spots, respectively.
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3: Figure S3), which rank on the top 3, 9, and 15 KEGG
pathways containing 49, 35, and 32 DEGs, respectively
(Table 4).
Since these three KEGG pathways are highly related to
each other, we analyzed their common DEGs and veri-
fied them by qPCR (Figure 3). First, 4 DEGs were found
in all the three pathways, including crk, mek, jnk, and
erk. qPCR data were in agreement with the transcrip-
tomic results, showing that all these 4 genes are upregu-
lated in the Ras1CA-overexpressed PSG (Figure 4A).
Second, 5 DEGs were observed in both “pathways in
cancer” and “insulin signaling pathway”, including pi3kl,
pi3ks, cbl1, cbl2, and cbl3 (Figure 4B). The transcrip-
tomic results and qPCR data showed that pi3ks, cbl1,
cbl2, and cbl3 are all upregulated by Ras1CA, whereas
the qPCR data of pi3kl did not match its transcriptomic
result suggesting it might also be upregulated by Ras1CA.
Third, there were 3 DEGs in both “pathways in cancer”
and “MAPK signaling pathway”, including fgfr1, pkc, and
fgfr2. The transcriptomic results and qPCR data showed
the fgfr1 and pkc are upregulated and downregulated by
Ras1CA, respectively, while fgfr2 might be downregulated
by Ras1CA (Figure 4C). Finally, pka, a single DEG in
both “insulin signaling pathway” and “MAPK signaling
pathway”, was downregulated by Ras1CA (Figure 4D).
We randomly selected some DEGs in each individual
pathway for qPCR verification (Figure 5). In “pathways
in cancer”, both the transcriptomic results and qPCR
data revealed that 7 DEGs, including cdk4/6, ptenl, fu,cdk2, ral, faks, and elongb, are all upregulated by Ras1CA,
while fakl is downregulated. Although the transcriptomic
results suggested that ptens and smo are upregulated by
Ras1CA, qPCR data showed that they might be downreg-
ulated (Figure 5A). In “insulin signaling pathway”, 7
DEGs, including rheb, fasl, fass, apkc, apkc, eif4e, and
ampk, are all upregulated by Ras1CA, while phk is down-
regulated, and shc might be upregulated (Figure 5B). In
“MAPK signaling pathway”, p38 and mapkapk are up-
regulated by Ras1CA, while hsp70s and tak are downreg-
ulated, and daxx might be downregulated (Figure 5C).
qPCR verification of DEGs in “purine metabolism” and
“pyrimidine metabolism”
Interestingly, abundant DEGs were annotated in two major
nucleotide metabolism pathways, “purine metabolism” and
“pyrimidine metabolism” (Additional file 4: Figure S4 and
Additional file 5: Figure S5), ranking on the top 1 and 6
KEGG pathways which contain 67 and 42 DEGs, respec-
tively (Table 3).
We thus verified the above-mentioned hypothesis that
Ras might activate nucleotide metabolism by qPCR verifi-
cation of some randomly selected DEGs in both “purine
metabolism” and “pyrimidine metabolism” (Figure 6). We
first analyzed 10 of the 28 common DEGs in both path-
ways, including pole4, pole2, rpb5, rpc10, rpb4, rpc37, apf,
itpa, rpc25, and nt5e. Different from the transcriptomic
results, qPCR data suggest that rpc25 and nt5e might
be upregulated rather than downregulated by Ras1
(Figure 6A). We then analyzed 5 of the 39 DEGs only
in “purine metabolism”, including adk, allc, prps, pde, and
gart. Although gart expression was inconsistent between
its transcriptomic and qPCR data, all the other DEGs are
upregulated (Figure 6B). In addition, urh1, one of DEGs
only in “pyrimidine metabolism” is also upregulated
(Figure 6C). Taken together, Ras1CA overexpression in the
PSG upregulates most, if not all, DEGs in “purine meta-
bolism” and “pyrimine metabolism”.
Identification of Ras1 downstream signals in regulating
DEGs by small-molecule inhibitor treatments
We next investigated which downstream pathway(s) that
Ras1 utilizes to regulate DEGs in the Bombyx PSG by
injecting small-molecule inhibitors of the Ras down-
stream effectors (Rafi, Raf inhibitor; LY294002, PI3K in-
hibitor; rapamycin, TORC1 inhibitor; 15 μg/larva) into
the Ras1CA-overexpressed silkworm larvae [10]. Some
Ras1CA-upregulated DEGs, which are consistent in both
transcriptomic results and qPCR data, were chosen for
inhibitor treatment experiments by qPCR analysis to
examine their expression levels.
First, we detected the common DEGs annotated in
“pathways in cancer”, “insulin signaling pathway”, and






























































































































































































































































































































































































































































































































































































































































































































































Figure 2 Histogram presentation of Gene Ontology classification of DEGs in Ras1CA-overexpressed and WT PSGs. The results are
summarized in three main categories: biological process (A), cellular component (B), and molecular function (C). The right y-axis indicates the
number of genes in a category. The left y-axis indicates percentage of DEGs in a specific category. Different color represents different percentage:
dark blue, 0-5%; dark red, 5-10%, dark purple, 10-20%; green, 20-30%; orange, 30-40%; red, over 40%.
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Table 3 A comparison between qPCR verification results and transcriptomic data of DEGs in five KEGG pathways










Pathways in cancer 22 18 81.8% 4 18.2%
Insulin signaling 18 16 88.9% 2 11.1%
MAPK signaling 13 11 84.6% 2 15.4%
Purine metabolism 15 12 80.0% 3 20.0%
Pyrimidine metabolism 11 8 72.7% 3 27.3%
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the three pathways were decreased to 10-20% by
Rafi and 20-40% by LY294002, whereas rapamycin treat-
ment showed weaker inhibitory effects (40-60%)
(Figure 7A). For pi3ks, cbl2, and cbl3, the three DEGs
presented in both “pathways in cancer” and “insulin
signaling pathway”, LY294002 and rapamycin showed
the strongest and weakest inhibitory effects, respectively
(Figure 7B). By contrast, rapamycin strongly inhibitedTable 4 Number of KEGG orthologs (KO) in pathways with to
Pathway Pathway ty
ko00230, Purine metabolism Metabolism
ko03040, Spliceosome Genetic info
ko05200, Pathways in cancer Human dis
ko03013, RNA transport Genetic info
ko05166, HTLV-I infection Human dise
ko00240, Pyrimidine metabolism Metabolism
ko04110, Cell cycle Cellular pro
ko04510, Focal adhesion Cellular pro
ko04910, Insulin signaling pathway Organisma
ko03008, Ribosome biogenesis in eukaryotes Genetic info
ko05016, Huntington's disease Human dise
ko04146, Peroxisome Cellular pro
ko00561, Glycerolipid metabolism Metabolism
ko05010, Alzheimer's disease Human dise
ko04010, MAPK signaling pathway Environme
ko04111, Cell cycle - yeast Cellular pro
ko04144, Endocytosis Cellular pro
ko04810, Regulation of actin cytoskeleton Cellular pro
ko00564, Glycerophospholipid metabolism Metabolism
ko05169, Epstein-Barr virus infection Human dise
ko00260, Glycine, serine and threonine metabolism Metabolism
ko04120, Ubiquitin mediated proteolysis Genetic info
ko04113, Meiosis - yeast Cellular pro
ko03010, Ribosome Genetic info
ko04145, Phagosome Cellular pro
The datas marked with boldface were chosen for further analysis.expression of fgfr1, the DEGs distributed in “pathways in
cancer” and “MAPK signaling” (Figure 7C).
Second, we detected the individual DEGs anno-
tated in “pathways in cancer” (Figure 7D), “insulin
signaling pathway” (Figure 7E), and “MAPK signaling
pathway” (Figure 7F) by qPCR. For most of the
DEGs, Raf inhibitor exhibited the strongest inhibi-
tory effects, while rapamycin showed little to no in-
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Figure 3 DEGs distribution in “pathways in cancer”, “insulin signaling pathway” and” MAPK signaling pathway”. (A) Showing the
number of DEGs. (B) Showing the common DEGs.
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http://www.biomedcentral.com/1471-2164/15/182Third, we detected the DEGs annotated in “purine me-
tabolism” and “pyrimidine metabolism” (Figure 8). For
DEGs in both pathways, LY294002 exhibited the strongest
inhibitory effects (Figure 8A). For the two DEGs only in
“purine metabolism”, Raf inhibitor and LY294002 showed
the strongest inhibitory effects on pde and allc, respec-
tively (Figure 8B).
In summary, inhibitors of the Ras downstream effectors
showed inhibitory efforts on different DEGs to varying de-
grees indicating that both Raf-MAPK and PI3K-TORC1
pathways are involved in the transcriptional regulation of
those DEGs. Interestingly, similar results were observed in


































































































































































































































Figure 4 Verification of transcriptomic results of DEGs in “pathways i
pathway” by qPCR. (A) Common DEGs in all the three pathways. (B) Com
Common DEGs in “pathways in cancer” and “MAPK signaling pathway”. (D)
pathway”. The transcriptional results of DEGs (FPKM) are marked with black
marked with red and green. The mis-matched DEGs are marked with gray.Discussion
Ras1 transcriptionally activates its downstream Raf-MAPK
and PI3K-TORC1 pathways
On a genome-wide scale, the identification of Ras-
responsive genes has become feasible using different
transcriptomic tools. For example, subtractive suppres-
sion hybridization was performed in immortalized,
non-tumorigenic rat embryo fibroblasts and in Ras-
transformed cells. The results have shown that many
DEGs are involved in almost all aspects of cellular
growth control and cell survival [29]. A microarray
was conducted in RasCA-transformed mouse embry-
onic fibroblasts, showing that many genes encoding


















































































































n cancer”, “insulin signaling pathway”, and “MAPK signaling
mon DEGs in “pathways in cancer” and “insulin signaling pathway”. (C)
Common DEG in “insulin signaling pathway” and “MAPK signaling
. The q-PCR data of DEGs upregulated and downregulated by Ras1 are
WT: wildtype; Ras1: Fil-GAL4 > UAS-Ras1CA.
AB
C
Figure 5 Verification of transcriptomic results of DEGs only in “pathways in cancer”, “insulin signaling pathway”, or “MAPK signaling
pathway” by qPCR. DEGs only in “pathways in cancer” (A), “insulin signaling pathway” (B), “MAPK signaling pathway” (C). The transcriptional
results of DEGs (FPKM) are marked with black. The q-PCR data of DEGs upregulated and downregulated by Ras1 are marked with red and green.
The mis-matched DEGs are marked with gray. WT: wildtype; Ras1: Fil-GAL4 > UAS-Ras1CA.
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http://www.biomedcentral.com/1471-2164/15/182results of Ras-induced gene expression profiling stud-
ies based on subtractive suppression hybridization and
microarrays were extensively summarized [27], reveal-
ing that Kruppel-like factor 5, the CD44 antigen, and
members of the epidermal growth factor (EGR)-family
are common Ras downstream effectors [28]. Using
Illumina-Solexa sequencing to analyze DEGs in the
PSG, here we found that many Ras1-induced genes






























































































































































































































Figure 6 Verification of transcriptomic results of DEGs in “purine met
DEGs in both pathways. (B) DEGs only in “purine metabolism”. (C) DEGs on
(FPKM) are marked with black. The q-PCR data of DEGs upregulated and dow
DEGs are marked with gray. WT: wildtype; Ras1: Fil-GAL4 > UAS-Ras1CA.signaling”, and “MAPK signaling pathway”. The tran-
scriptomic analysis illustrates that, apart from phos-
phorylational regulation, Ras1 can also activate its
downstream Raf-MAPK and PI3K-TORC1 pathways at
the transcriptional level (Figure 3, 4 and 5, Additional
file 1: Figure S1, Additional file 2: Figure S2 and Add-
itional 3: Figure S3, Table 4). To our knowledge, this
is the first report that Ras1 can transcriptionally acti-






















































































































































































abolism” and “pyrimidine metabolism” by qPCR. (A) Common
ly in “pyrimidine metabolism”. The transcriptional results of DEGs





















































































































Figure 8 Small-molecule inhibitor treatments to identify which Ras1 downstream signaling pathways are involved in regulating DEGs
in “purine metabolism” and “pyrimidine metabolism”. (A) Common DEGs in both pathways. (B) DEGs only in “purine metabolism”. Small-molecule
chemical inhibitors of the Ras downstream effectors (Rafi, Raf inhibitor; LY294002, PI3K inhibitor; Rapa, rapamycin, TORC1 inhibitor; 15 μg/larva) are injected

















































































































































































































































































































Figure 7 Small-molecule chemical inhibitor treatments to identify which Ras1 downstream signaling pathways are involved in
regulating DEGs in “pathways in cancer”, “insulin signaling pathway”, and “MAPK signaling pathway”. (A) Common DEGs in all the three
pathways. (B) Common DEGs in “pathways in cancer” and “insulin signaling pathway”. (C) A common DEG in “pathways in cancer” and
“MAPK signaling pathway”. (D) DEGs only in “pathways in cancer”. (E) DEGs only in “insulin signaling pathway”. (F) DEGs only in “MAPK signaling
pathway”. Small-molecule chemical inhibitors of the Ras downstream effectors (Rafi, Raf inhibitor; LY294002, PI3K inhibitor; Rapa, rapamycin, TORC1
inhibitor; 15 μg/larva) are injected into Ras1CA-overexpressed silkworm larvae. Inhibitors are marked with different color: black, DMSO as a control;
red: Raf inhibitor; green, LY294002; blue: rapamycin.
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Figure 9 A proposed model shows that Ras1CA activates its
downstream Raf-MAPK and PI3K-TORC1 pathways at both
phosphorylational and transcriptional levels and upregulates
genes in “nucleotide metabolism” for inducing endoreplication.
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http://www.biomedcentral.com/1471-2164/15/182Ras1 transcriptionally activates genes involved in
nucleotide metabolism and cell cycle for increasing DNA
content and inducing endoreplication
Earlier studies have shown that a lot of key enzymes of
nucleotide metabolism and DNA biosynthesis, such as
CTP synthetase, thymidylate synthase, dihydrofolate re-
ductase, IMP dehydrogenase, ribonucleotide reductase,
DNA polymerase, and DNA methyltransferase, are mark-
edly upregulated in certain tumor cells, which supports
the excessive proliferation of transformed cells [31]. The
microarray conducted in RasCA-transformed mouse em-
bryonic fibroblasts revealed that many genes encoding
DNA-associated proteins (involved in DNA replication
and DNA repair) are upregulated as well [30]. Interest-
ingly, a microarray analysis of Ras-overexpressed hemo-
cytes in the fruitfly, Drosophila melanogaster, showed that
a large number of genes that are functionally important in
cell cycle regulation and DNA replication were upregu-
lated [32]. We have previously shown that compared to
the WT PSG, total DNA content is nearly doubled in the
Ras1CA-overexpressed PSG [2]. Moreover, in comparison
with the WT PSG, BrdU incorporation in the Ras1CA-
overexpressed PSG is much higher indicating enhanced
endoreplicative cycles [2]. In this study, we found many
Ras1-induced genes are enriched in “purine metabolism”,
“pyrimidine metabolism”, and “cell cycle”, which ranks top
1, 6, and 7, respectively (Figure 6, Table 3). Therefore, it is
likely that Ras1 transcriptionally activates genes involved
in nucleotide metabolism and cell cycle for increasing
DNA content and inducing endoreplication in the PSG.
Conclusion
About 46 years before, it has been hypothesized that fi-
broin production in the Bombyx PSG is directly propor-
tional to silk yield and determined by its gland size and
protein synthesis [1]. Based on this hypothesis, we have
generated a transgenic silkworm, Fil > Ras1CA, for im-
proving silk yield. Importantly, overexpression of Ras1CA
increases gland size and protein synthesis in the PSG,
improving fibroin production and silk yield by 60%. At
the molecular level, we have determined that Ras activa-
tion enhances phosphorylation levels of Ras downstream
effector proteins, Raf and PI3K110, and thus activates its
downstream Raf-MAPK and PI3K-TORC1 pathways [2].
To better understand the molecular mechanisms how
Ras1CA overexpression in the PSG improves fibroin pro-
duction and silk yield, we performed both proteomics
and transcriptomics. Unfortunately, in spite of the dis-
covery that Ras1CA upregulates bcpi to inhibit cathepsin
activity and thus to prevent PSG destruction, we were
not able to better understand how Ras1CA improves fi-
broin production and silk yield using proteomics [10].
The transcriptomic results of the Ras1CA-overexpressed
PSG presented here underlie a wide array of DEGs inmany KEGG pathways. Importantly, we have discovered
that a large number of DEGs in “pathways in cancer”, “in-
sulin signaling”, and “MAPK signaling pathway” are
upregulated by Ras1CA overexpression in the PSG. Com-
bined with our previous findings [2] and the present studies
(Figure 9), we conclude that Ras1 activates its downstream
Raf-MAPK and PI3K-TORC1 pathways at both phosphory-
lational and transcriptional levels. Moreover, we find that
Ras1 upregulates genes in “nucleotide metabolism” and
“cell cycle” for increasing DNA content and inducing
endoreplication (Figure 9). This study has advanced our
knowledge on how Ras1CA overexpression in the PSG im-
proves fibroin production and silk production.
Methods
Animals
The Bombyx strain, Dazao, was reared on fresh mulberry
leaves in the laboratory at 25°C under 14 h light/10 h
dark cycles. The transgenic silkworm Fil > Ras1CA was
obtained as described previously by crossing Fil-GAL4
with UAS-Ras1CA [2]. The transgenic silkworms were
reared under the same condition as the WT silkworms.
Dissection of the PSGs
The silkworm PSGs were dissected from the Ras1CA-
overexpressed and WT silkworms at the early wandering
stage, when silkworms just begin to spin [2,10]. The
PSGs were used for Illumina-Solexa sequencing and
qPCR. Throughout the paper, all qPCR experiments
were performed in 3 biological duplicates.
RNA extraction
For Illumina sequencing, total RNA from the Ras1CA-
overexpressed PSG or the WT PSG was isolated with
TRIzol (Invitrogen, Carlsbad, CA, USA). To remove any
residual DNA, samples were pretreated with RNase-free
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30 minutes at 37°C. RNA quality was first verified using
a 2100 Bioanalyzer RNA Nanochip (Agilent, Santa Clara,
CA) with RNA Integrity Number (RIN) value over 8.5.
RNA was then quantified using NanoDrop ND-1000
Spectrophotometer (NanoDrop, Wilmington, DE).
Library preparation and Illumina sequencing
The RNA-seq libraries were prepared using Illumina’skit
following the manufacturer’s protocol (Illumina, San
Diego, CA). Approximately 20 μg of total RNA from the
Ras1CA-overexpressed PSG or the WT PSG was used to
isolate mRNA using Sera-mag Magnetic Oligo (dT)
Beads (Illumina). To avoid cDNA synthesizing bias by
priming, the purified mRNA was fragmented into small
pieces (100–400 bp) using divalent cations at 94°C for
5 minutes. The double-stranded cDNA was first synthe-
sized using the SuperScript Double-Stranded cDNA Syn-
thesis kit (Invitrogen, Camarillo, CA) with random
hexamer (N6) primers (Illumina). Then the synthesized
cDNA was subjected to end-repair and phosphorylation
using T4 DNA polymerase, Klenow DNA polymerase,
and T4 PNK. These repaired cDNA fragments were 3'
adenylated using Klenow Exo- (3' to 5' exo minus, Illu-
mina).Illumina paired-end adapters were ligated to the
ends of these 3'-adenylated cDNA fragments.The ligated
cDNA was then enriched with 15 rounds of PCR ampli-
fication using PCR Primer PE 1.0 and PCR Primer PE
2.0 (Illumina) with Phusion DNA Polymerase.The librar-
ies were sequenced using Illumina Highseq 2000 plat-
form according to the manufacturer’s instructions.
Illumina sequencing was performed at Suzhou Encode
Genomics Biotechnology Co-Ltd (Encode Genomics;
Suzhou, China).
Raw data preprocess
Preprocessing was carried out with a stringent filtering
process. First, we removed reads that do not pass the
built-in Illumina's software Failed-Chastity filter accord-
ing to the relation "failed-chastity < = 1", using a chastity
threshold of 0.6, on the first 25 cycles. Second, we dis-
carded all reads with adaptor contamination. Third,
we ruled out low-quality reads containing ambiguous
sequences "N". Finally, the reads with more than 10%
Q < 20 bases were also removed.
Genome mapping and abundance analysis
Quality-filtered reads were then aligned to the Bombyx
genome (release_2.0, ftp://silkdb.org/pub/current/Gen-
ome/ by TopHat (version 2.0.4) [20] with the parameters
“–bowtie1 -r 0 –mate-std-dev 50 -N 3–solexa1.3-quals”
(insert size is set as 0). The resulting alignment data
from Tophat were then fed to an assembler Cufflinks
(version 2.0.1) to assemble aligned RNA-Seq reads intosilkworm genome database (silkworm_glean.gff ) and
silkworm gene database (silkgenome.fa). Unigene abun-
dances were measured by Fragments per kb of exon per
million fragments mapped (FPKM) using the formula
FPKM = (1,000,000*C)/ (N*L*1,000)[21].Functional annotations
The DEGs in Ras1CA-overexpressed and WT PSGs were
functional annotated by GO annotation and KEGG an-
notation. For GO annotation, the DEGs were first
blasted against uniprot knowledgebase (including Swiss-
Prot and TrEMBL) (UniProtKB; http://www.uniprot.org)
to get uniprot IDs. Then the uniprot IDs were assigned
to GO terms at three basic catergories including mo-
lecular function, biological process, and cellular compo-
nent. For KEGG annotation, DEGs were functionally
annotated with KAAS (KEGG Automatic Annotation
Server) by BLAST comparisons against the manually cu-
rated KEGG GENES database. The result contains KO
(KEGG Orthology) assignments and automatically gen-
erated KEGG pathways.qPCR
Total RNA of the Ras1CA-overexpressed PSG or the WT
PSG was extracted using TRIzol (Invitrogen). qPCR was
performed as previously described [2,33]. The primers
used in this paper are listed in Additional file 6: Table S1
(Supporting Information).Chemical inhibitor treatment
Small-molecule chemical inhibitors of the Ras downstream
effectors (Rafi, Raf inhibitor, Santa Cruz; LY294002, PI3K
inhibitor, Sigma; rapamycin, TORC1 inhibitor, Sigma;
15 μg/larva) were injected into the Fil > Ras1CA larvae
at the EW stage. At 24 h after the first injection, the PSGs
were dissected for qPCR as previously described [10].Statistics
Experimental data were analyzed with the Student’s t-test
and ANOVA. t-test: *, p < 0.05; **, p < 0.01. ANOVA: the
bars labeled with different lowercase letters are signifi-
cantly different (p < 0.05). Throughout the paper, values
are represented as the mean ± standard deviation of at
least 3 independent experiments.Availability of supporting data
The RNA-seq raw data were deposited to NCBI SRA
with the accession number SRP026709 (http://www.ncbi.
nlm.nih.gov/sra/?term=SRP026709).
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Additional file 1: Figure S1. DEGs distributed in “pathways in cancer”
(KEGG) signaling network. DEGs are marked with red square.
Additional file 2: Figure S2. DEGs distributed in “insulin signaling
pathway” (KEGG) signaling network. DEGs are marked with red square.
Additional file 3: Figure S3. DEGs distributed in “MAPK signaling
pathway” (KEGG) signaling network. DEGs are marked with red square.
Additional file 4: Figure S4. DEGs distributed in “purine metabolism”
(KEGG) signaling network. DEGs are marked with red square.
Additional file 5: Figure S5. ADEGs distributed in “pyrimidine
metabolism” (KEGG) signaling network. DEGs are marked with red square.
Additional file 6: Table S1. List of primers used for qPCR verification.
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